Riskpilot← Back to searchSign inGet full accessEximicon AB
ABActiveOrg 5567462253Hults Sörgårdsväg 3 BMedical specialists activities · NACE 8622Est. 20071 employees
Revenue 2025
SEK 2,6M
+60% vs 2024
EBITDA margin
55.8%
+125% vs 2024
Equity ratio
86.3%
Financial strength
Net profit 2025
SEK 895K
+68% vs 2024
| Revenue | SEK 2,6M | +60% |
| EBITDA | SEK 1,5M | +125% |
| Net profit | SEK 895K | +68% |
| Total assets | SEK 3,7M | +37% |
| Equity | SEK 3,2M | +25% |
| Employees | 1 | — |
Legal name
Eximicon AB
Org number
5567462253
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 december 2007
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukvård, förebygga, diagnostisera, utreda och behandla sjukdommar och skador samt därmed förenlig verksamhet. Bedriva friskvård och rehabilitering i form av personlig träningsrådgivning, kostrådgivning, personlig utveckling och mental träning samt därmed förenlig verksamhet. Bedriva uthyrning/leasing av musikinstrument inklusive uthyrning i att spela musikinstrument samt därmed förenlig verksamhet.
Address
Hults Sörgårdsväg 3 B
Email
nenze1@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 449 | −0 | 40 | 1 636 | 2 610 |
| Staff expenses | — | −717 | −860 | −928 | −1 075 |
| EBITDA | 522 | −776 | −942 | 647 | 1 457 |
| Depreciation & amort. | −86 | −86 | −86 | −86 | — |
| EBIT | 436 | −861 | −1 028 | 561 | 1 457 |
| Net financials | 6 | 5 | 15 | 48 | 43 |
| Profit before tax | 472 | 20 | −299 | 609 | 1 126 |
| Tax | −104 | −17 | — | −76 | −231 |
| Net profit | 368 | 4 | −299 | 533 | 895 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 500 | 3 349 | 2 098 | 2 723 | 3 743 |
| Equity | 2 849 | 2 603 | 2 054 | 2 587 | 3 231 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 60 | 32 | 45 | 137 | 137 |
| Total debt | 60 | 32 | 45 | 137 | 137 |
EBITDA margin
55.8%
This company
15.8%
Market median
+253% vs market
20212025
Equity ratio
86.3%
This company
38.2%
Market median
+126% vs market
20212025
Return on equity
27.7%
This company
18.4%
Market median
+51% vs market
20212025
Net profit margin
34.3%
This company
8.1%
Market median
+323% vs market
20212025
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20212025
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
SM Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Eximicon AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Magnus Ekendal | Audit | 0 companies |
| Nenad Zeba | Board of Directors | 0 companies |
| Lisa Viola Hallgren | Deputy Board Member | 0 companies |
| Fredrik Olenborg | Deputy Board Member | 0 companies |
| Staffan Gustav Åke Sigurd Ligardh | Deputy Board Member | 0 companies |